Analytical Data
-
基因名
RBM7
- Application
-
别名
RBM7; RNA-binding protein 7; RNA-binding motif protein 7
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9Y580
-
表达区间
1-266 aa
-
氨基酸序列
MGAAAAEADR TLFVGNLETK VTEELLFELF HQAGPVIKVK IPKDKDGKPK QFAFVNFKHE VSVPYAMNLL NGIKLYGRPI KIQFRSGSSH APQDVSLSYP QHHVGNSSPT STSPSRYERT MDNMTSSAQI IQRSFSSPEN FQRQAVMNSA LRQMSYGGKF GSSPLDQSGF SPSVQSHSHS FNQSSSSQWR QGTPSSQRKV RMNSYPYLAD RHYSREQRYT DHGSDHHYRG KRDDFFYEDR NHDDWSHDYD NRRDSSRDGK WRSSRH
-
分子量
30.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human C9orf3 Protein，GST
Cat：PA2000-6382
Recombinant Human RBM6 Protein，GST
Cat：PAX2000-10810
Protein Description
RBM7 (RNA-binding motif protein 7) is a critical regulator of RNA processing and has garnered attention in the context of cancer biology and cellular stress responses. It is known to participate in the formation of the spliceosome, a complex responsible for the removal of introns from pre-mRNA, thus influencing gene expression. Dysregulation of RBM7 has been implicated in various malignancies, making it a potential target for therapeutic intervention. Additionally, studies have shown that RBM7 can interact with other RNA-binding proteins and contribute to the stability and localization of specific mRNAs, suggesting its role in post-transcriptional regulation. Recent advances in protein engineering and recombinant DNA technology have facilitated the production of RBM7 as a recombinant protein, enabling detailed structural and functional analyses. Understanding the precise mechanisms by which RBM7 operates could provide valuable insights into its function in both normal cellular processes and disease states, paving the way for novel strategies in targeting RNA processing pathways for therapeutic benefit.
